📢We’re delighted to kick off the 2026 CGA-IGC webinar series on #HereditaryGICancer syndromes with our first session:
🧬 “Novel Detection Methods for Endometrial Cancers in Lynch Syndrome”
📅 Friday, February 13, 2026
🔗 Save the date and register here: cgaigc.com/webinars
➡️Not yet a CGA-IGC member or need to renew? Join or renew today to access this webinar and a full program of CGA-IGC webinar series throughout 2026.
📍As a CGA-IGC member, you have on-demand access to our past webinar series from 2018–2025, making it easy to revisit key sessions and explore important topics anytime, at your convenience.
👉 Join at cgaigc.com
Emma Keel (she/her) retweeted
As 2025 comes to a close, we send a heartfelt thank you to our members and the wider #HereditaryGICancer community for your continued support of CGA-IGC 💙
We’re grateful for your engagement and look forward to connecting and collaborating with you in the year ahead
Emma Keel (she/her) retweeted
📢Don’t miss our final webinar of 2025!
🗓 Oct 29 | 12 pm ET / 9 am PT
➡️Featuring Colin Pritchard, Tomas Walsh & Angela Jacobson from @UW
➡️They’ll 🗣️“Advances in Genetic Testing for Hereditary Cancers, ” including mosaicism testing & 4 #HereditaryGICancer cases using long-read sequencing.
➡️ Register now 🔗 cgaigc.com/webinar
#HereditaryCancer #CGAIGC
Emma Keel (she/her) retweeted
💙 The CGA-IGC Annual Meeting is not only a hub for professional networking 🤝 it’s also a vital platform for gaining practical, up-to-date insights to support the care of patients and families affected by hereditary GI cancer 🧬
➡️Missed joining us at this year’s Annual Meeting in St. Louis? 🌆
Don’t miss the short discussion here
👉🔗tinyurl.com/msshdb5b between John Burn and Swati G. Patel at #CGAIGC25, sharing long-awaited results from the CaPP3 trial , a follow-up to the landmark CAPP2 study that first demonstrated aspirin’s ability 💊 to reduce cancer risk in people with #LynchSyndrome
#HereditaryGICancer
@MSpringerGC @asaf_maoz @EdEsplin @AlexMannucci @CavestroGM @pAla2Arg @MLaszkowskaMD @HannahAlison20 @HorganRoberta @RHuneburg @YingLiu88 @kevinjmonahan @lynchsyndrome @LynchSyndromeUK @StMarksGenomics @LynchSyndromeAU @LSLatinos @AjayBansal_KUMC
Emma Keel (she/her) retweeted
Calling all genetic counselors #genechat and clinicians that order #genetic testing — you’re not going to want to miss this talk! Join @CGAIGC for access to content like this (and get CEU’s!)
📢Join us for a timely and essential conversation: "Recontacting #Patients After Guideline Changes."
🗓️July 22
⏲️noon ET / 9am PT
✅️cgaigc.com/webinars
➡️As clinical guidelines, especially in hereditary cancer care, evolve with new evidence, what are the legal and ethical responsibilities of providers to recontact patients?
➡️We’re thrilled to welcome Jennifer Wagner, JD, PhD, a nationally recognized expert in genetics, law, and bioethics, who will share her interdisciplinary insights into this complex issue.
She’ll explore:
🔹 How changing guidelines affect clinical recommendations
🔹 Legal and ethical duties to recontact patients
🔹 Key differences between clinical patients and research participants
📍Don't miss this vital discussion, followed by a Q&A!
#HereditaryGICancer
Emma Keel (she/her) retweeted
One week left until the abstract submission deadline for poster presentations at #CGAIGC25! ⌛ We want to provide as many opportunities as possible for you to attend, so for this year only, we are offering a second chance to submit your research for poster presentation. Deadline coming up on Monday, July 28 - we won't extend this one! 🔗 bit.ly/41atu42
Emma Keel (she/her) retweeted
📢Happening tomorrow!
Webinar 4: Recontacting Patients after Guideline Changes!
📅 Tuesday, July 22 | noon ET / 9am PT
🧬 Register now 👉cgaigc.com/webinars
➡️How do we communicate these changes to patients after the fact?
🚨We’re thrilled to welcome Jennifer K. Wagner, an expert in genetics, law & bioethics, who brings a rare interdisciplinary lens to this complex issue.
⚖️ She’ll explore the ethical & legal implications of recontacting patients following new results or guideline updates & help clarify how responsibilities differ when recontacting:
👩🔬 Research participants
🩺 Clinical patients
📍Don't miss this timely & practical session, packed w/ insights & actionable takeaways.
#HereditaryGICancer
Emma Keel (she/her) retweeted
Don't miss tomorrow's deadline to submit your own Jeopardy team to take on the reigning champs at #CGAIGC25 in St. Louis! Teams can be built however you want them to be, but we strongly encourage multidisciplinary members from different institutions. Learn more & submit here 👉 bit.ly/3FLmHpH
Emma Keel (she/her) retweeted
📢This week is Familial Adenomatous Polyposis (FAP) Awareness Week—a great time to share our new partnership with the Roxanne and Henry Brandt Foundation, announced in March‼️
🙏 to their generous support, we're inviting applications for projects focused on improving the lives of those with FAP—whether through clinical, translational, or basic research, quality improvement, or patient engagement.
➡️Applications for this & two other grants close Friday, July 11, 2025.
📍Learn more and apply: cgaigc.com/grant-opportuniti…
Emma Keel (she/her) retweeted
📢We're thrilled to have a partnership with @cityofhope's Clinical Cancer Genetics Community of Practice (CCGCoP) that will benefit our members.
➡️Applications for @cityofhope CME/CEU/MOC-accredited Intensive Course in Genetic Cancer Risk Assessment are now open!
➡️The Intensive Course & Community of Practice help clinicians apply the latest in #genetics to improve #cancer risk assessment, prevention, and treatment.
📍Learn more & apply by August 1 here 👉cityofhope.org/ic
#HereditaryGICancer
Emma Keel (she/her) retweeted
🎥 Missed last week’s live webinar? No problem!
#CGAIGC members can now watch it on-demand — plus our full series from 2025 all the way back to 2018!
Not a member? Join here 👉 tinyurl.com/3r9df5w2
Earn CEUs & gain expert insights on hereditary GI cancer syndromes to better support your patients and their families.
Watch now 👉 cgaigc.com/webinars
#HereditaryGICancer #CEU #MedEd
Emma Keel (she/her) retweeted
📢Did you miss the #CGAIGCJS Tweetorial “Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6/PMS2-Associated #LynchSyndrome” by CGA-IGC communications committee member @DanLiMD?
➡️Take the time to see the full article here 👉 pubmed.ncbi.nlm.nih.gov/4001…
read the 🧵below👇
#HereditaryGICancer #RedJournal
1/Welcome to #CGAIGCJS Tweetorial on “Neoplasia Detection Through Colonic Surveillance Among Young Individuals With MSH6/PMS2-Associated #LynchSyndrome” by CGA-IGC communications committee member @DanLiMD
Full article in @AmJGastro at DOI: 10.14309/ajg.0000000000003369 👉pubmed.ncbi.nlm.nih.gov/4001…
🧵
#HereditaryGICancer #RedJournal
Emma Keel (she/her) retweeted
📢We're delighted to release our 2nd🎙️of our 3-part 🎙️series on #research collaborations‼️
👂to the 🎙️here 👉tinyurl.com/3eccunar
➡️This episode is hosted by Emma Keel, MS, CGC (@pAla2Arg), who spoke with @OphirGilad, MD, the lead of the #Gastric CDH1 Multicenter Consortium
📍Learn about this consortium's strategies for ensuring data quality & the goal of creating the largest cohort of #CDH1 patients to date to better understand the syndrome‼️
#HereditaryGICancer
Emma Keel (she/her) retweeted
📢Join us for another webinar featuring 3⃣ 👍 speakers from @StJudeResearch
🗓️Tue, May 27, 205
⌚️ 12 pm ET / 9 am PT
✍️cgaigc.com/webinars
➡️This webinar is essential for anyone looking to enhance their daily practice
The team @StJudeResearch will present an overview of care for adolescents & young adults (AYA) w/ #HereditaryGICancer syndromes. The session will emphasize how the #Cancer Predisposition Program at St. Jude Research facilitates the transition from #pediatric to adult care‼️
Emma Keel (she/her) retweeted
📢We're seeking European case presentations for the April 23 Hereditary Live session at 16.00 UTC / 18.00 CEST.
➡️Submit it here 👉surveymonkey.com/r/Hereditar…
@HorganRoberta @LValleResearch @RHuneburg, @CavestroGM @GabrielaMoslein any ideas?
do you have any challenging, rare, or interesting #HereditaryGICancer cases from your countries that would be of interest and benefit from being shared & discussed?
➡️Hereditary Live provides a unique platform for clinicians to present challenging cases and receive real-time feedback from global experts.
📌It's a👍opportunity for some global collaboration😊
Emma Keel (she/her) retweeted
There is still time to register for the @NateraOncology x #CGAIGC webinar happening next week‼️
🗓️Wednesday, February 12th, 2025
⏱️7:00 PM ET | 4:00 PM PT
➡️Register here 👉tinyurl.com/mvsvpytp
Leveraging ctDNA to enhance identification of #HereditaryGICancer will be presented by expert speakers Drs Shruti Singh, Asaf Maoz (@asaf_maoz)
& AdamElNaggar (@onco_punch )
Join us for insightful #GICancer case studies‼️
@CentralParkWMD @ryanhuey @drjasonstarr
@NiuSanford @Amitmahipal79 @benweinbergmd
@rachnatshroff @WuGiOnc @SalemGIOncDoc
@SKamath_MD @BiachiTiago @sundar__raghav
@KlempnerSam @RyanMoyMDPhD @DrEstfan
@SheRiseRogersMD @benfergvson @ILSONDavid
@heinrich_kat @LFonkoua @MayCho_MD
@PelinCinarMD @josiebakerGC @aparna1024 @christinedrogan
Emma Keel (she/her) retweeted
Happy Thanksgiving‼️
As you prepare for #Thanksgiving, remember it’s also #NationalFamilyHistoryDay
This is a👍opportunity to sit down with your #family & learn more abt your👪health history, esp. regarding #Cancer
@SanjeevaniArora @josiebakerGC @christinedrogan @pAla2Arg
Emma Keel (she/her) retweeted
The discussion of early detection of pancreatic cancer continues with blood based tests. Fay Kastrinos from @columbiacancer shares the state and the future of liquid biopsies in PDAC. #CGAIGC24
Emma Keel (she/her) retweeted
Excellent talk by Rachael Hodan from @StanfordHealth @CGAIGC
Risk of breast/chest cancer
📣cis woman: 1:8
📣Tranfeminine: 1:150
📣Transmasuline 1:300
@UCSFHospitals
@UCSFCancer
Emma Keel (she/her) retweeted
Hepatobiliary cancers: germline genetic associations and when to test @KirkWangensteen #CGAIGC24






















